[조사 보고서] 세계의 마우스 모델 시장 (~2029년) : 근교계, 이계 교배, 하이브리드

■ 영문 제목 : Mice Model Market by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology, Immunology), Application (Research, Drug Discovery) - Global Forecast to 2029
	■ 상품코드 : BT2192-24 ■ 조사/발행회사 : MarketsandMarkets ■ 발행일 : 2024년 2월 ■ 페이지수 : 369 ■ 작성언어 : 영문 ■ 보고서 형태 : PDF ■ 납품 방식 : Email (주문후 24시간내 납품) ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 바이오

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User	USD4,950 ⇒환산￦6,682,500	견적의뢰/주문/질문
Multi User (Five User)	USD6,650 ⇒환산￦8,977,500	견적의뢰/주문/질문
Corporate License	USD8,150 ⇒환산￦11,002,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

"세계의 마우스 모델 시장은 예측 기간 동안 연평균 8.1%의 성장률로 2024년 약 15억 달러에서 2029년 22억 달러에 달할 것으로 예상됩니다." 이 시장의 성장은 새로운 치료법을 발견하고 개발하기 위한 연구 개발 노력과 연구에서의 마우스 모델 채택, 종양학에서 개인 맞춤형 치료제에 대한 관심 증가에 기인한 것으로 분석됩니다.

"2023년 모델 유형 및 서비스별로 가장 큰 점유율을 차지할 모델 유형 세그먼트로 예상됩니다."
2023년 글로벌 마우스 모델 시장에서 모델 유형 및 서비스 부문이 가장 큰 점유율을 차지한 것은 모델 유형 부문입니다. 생쥐의 유전자가 인간과 유사하다는 점과 생쥐 모델이 인간 질병 연구, 신약 및 치료법 개발, 생물학적 과정의 이해에 중요한 역할을 한다는 점 등이 이 시장의 성장을 촉진하고 있습니다.

"아시아 태평양 지역은 2024~2029년 예측 기간 동안 마우스 모델 시장에서 가장 높은 CAGR로 성장할 것 입니다."
아시아 태평양 지역은 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다. 마우스 모델을 이용한 전임상 시험의 채택 증가, 헬스케어 분야의 호황 등 다양한 요인이 이 지역의 마우스 모델 시장의 성장을 촉진하고 있습니다.
새로운 기술 개발을 위한 제약 및 생명공학 기업의 자금 지원과 투자 증가는 아시아 태평양 지역의 마우스 모델 시장의 성장을 촉진할 것으로 예상됩니다. 아시아 태평양 지역은 생물의학 연구 및 의약품 개발에 대한 투자가 지속되고 있어 전임상 시험 및 신약개발을 지원하는 마우스 모델에 대한 수요가 증가하고 있습니다. 또한, 아시아 태평양 지역에서 만성 질환의 유병률이 증가함에 따라 질병 메커니즘을 더 잘 이해하고 잠재적인 치료법을 검증하기 위한 신뢰할 수 있는 동물 모델의 필요성이 증가하고 있습니다.

본 보고서를 위해 실시한 주요 인터뷰는 다음과 같이 분류할 수 있습니다.
- 응답자별 : 공급측 70%, 수요측 30%.
- 직급별 C레벨 : 55%, 이사급 : 20%, 기타 : 25%.
- 지역별 북미 45%, 유럽 20%, 아시아 태평양 20%, 중남미 10%, 중동 3%, 아프리카 2%

보고서 게재 기업 목록
• Charles River Laboratories (US)
• Inotiv (US)
• THE JACKSON LABORATORY (US)
• GemPharmatech (China)
• Cyanogen (US)
• Shanghai Model Organisms Center, Inc. (China)
• JSR Corporation (Japan)
• Biocytogen (China)
• TRANS GENIC INC. (Japan)
• Ozgene Pty Ltd. (Australia)
• Taconic Biosciences, Inc. (US)
• TransCure bioServices (France)
• Harbour BioMed (China)
• Marshall BioResources (US)
• genOway (France)
• Vivo Bio Tech Ltd. (India)
• ingenious targeting laboratory (US)
• Janvier Labs (France)
• Applied StemCell (US)
• Creative Animodel (US)
• JOINN Laboratories Co., Ltd. (China)
• Creative Biolabs (US)
• Crescendo Biologics (UK)
• Aragen Life Sciences (India)
• PolyGene (Switzerland)

조사 범위
본 조사 보고서는 마우스 모델 시장을 모델 유형 및 서비스(모델 유형 및 서비스), 기술(CRISPR/Cas9, 미세주입, 배아줄기세포 주입, 핵이식, 기타 기술), 치료 분야(종양학, 신경학, 대사성 질환, 면역학, 심혈관계 질환, 최종 용도(제약-바이오기업, 학계, CRO, CDMO), 지역별(북미, 유럽, 아시아 태평양, 중남미, 중동, 아프리카)로 구분하여 분석 했습니다. 이 보고서는 마우스 모델 시장의 성장에 영향을 미치는 주요 요인(촉진 요인, 동향, 과제, 기회 등)에 대한 자세한 정보를 제공합니다. 주요 산업 플레이어를 철저히 분석하여 비즈니스 프로필, 제품/서비스, 주요 전략, 제휴, 파트너십 및 계약에 대한 통찰력을 제공합니다. 또한, 마우스 모델 시장의 신제품 출시, 합병, 인수합병 등 최근 동향도 다루고 있습니다.

보고서 구매의 주요 이점
이 보고서는 전체 마우스 모델 시장과 그 하위 부문의 수익에 대한 가장 근접한 추정치를 제공함으로써 시장 리더와 신규 진입자에게 도움이 될 것입니다. 또한 이해관계자들이 경쟁 현황을 더 잘 이해하고, 비즈니스 포지셔닝을 개선하고, 적절한 시장 진입 전략을 수립할 수 있는 통찰력을 얻을 수 있도록 돕습니다. 이 보고서는 이해관계자들이 시장 동향을 이해하고 주요 시장 촉진 요인, 저해 요인, 기회 및 도전 과제에 대한 정보를 제공할 수 있도록 합니다.

이 보고서는 다음 사항에 대한 통찰력을 제공합니다.
- 시장 성장에 영향을 미치는 주요 촉진 요인(전임상 연구용 마우스 모델의 유전적 및 생리적 다양성, 마우스 임상 시험(MCT)에 대한 수요 증가, 종양학에서 개인 맞춤형 의료에 대한 수요 증가, 유전공학의 발전), 저해 요인(3D 도입, 윤리적 우려 및 규제 제한), 기회(생물 의학) 연구에서의 CRISPR 활용, 질병 특이적 모델에 대한 수요 증가), 도전 과제(대체 동물실험법 개발, 유전적 및 표현형 가변성)에 대한 분석을 제공합니다.
- 제품 개발/혁신 : 마우스 모델 시장에서 새롭게 출시되는 제품/서비스에 대한 심층적인 통찰력을 제공합니다.
- 시장 개발 : 유리한 시장에 대한 포괄적인 정보 - 이 보고서는 다양한 지역의 시장을 분석합니다.
- 시장 다각화 : 마우스 모델 시장의 신제품/서비스, 미개척 지역, 최근 개발 및 투자에 대한 상세 정보를 제공합니다.
- 경쟁사 평가 : Charles River Laboratories (US), Inotiv (US), THE JACKSON LABORATORY (US), GemPharmatech (China), Cyagen (US), Shanghai Model Organisms Center, Inc. (China), JSR Corporation (Japan), Biocytogen (China), TRANS GENIC INC. (Japan), Ozgene Pty Ltd. (Australia), Taconic Biosciences, Inc. (US), TransCure bioServices (France), Harbour BioMed (China), Marshall BioResources (US), genOway (France), Vivo Bio Tech Ltd. (India), ingenious targeting laboratory (US), Janvier Labs (France), Applied StemCell (US), Creative Animodel (US), JOINN Laboratories Co., Ltd. (China), Creative Biolabs (US), Crescendo Biologics (UK), Aragen Life Sciences (India), 및 PolyGene (Switzerland)) 등입니다.

■ 보고서 개요

1 서론
2 조사 방법
3 개요
4 프리미엄 인사이트
5 시장 개요
6 세계의 마우스 모델 시장 규모 : 모델 유형 및 서비스별
7 세계의 마우스 모델 시장 규모 : 기술별
8 세계의 마우스 모델 시장 규모 : 치료 영역별
9 세계의 마우스 모델 시장 규모 : 용도별
10 세계의 마우스 모델 시장 규모 : 최종 용도별
11 세계의 마우스 모델 시장 규모 : 지역별
12 경쟁 현황
13 기업 정보
14 부록

■ 보고서 목차

1 INTRODUCTION 51
1.1 STUDY OBJECTIVES 51
1.2 MARKET DEFINITION 51
1.2.1 INCLUSIONS & EXCLUSIONS 52
1.3 MARKET SCOPE 53
1.3.1 MARKET SEGMENTATION 53
1.3.2 REGIONS COVERED 54
1.4 YEARS CONSIDERED 54
1.5 CURRENCY CONSIDERED 55
1.6 STAKEHOLDERS 55
1.7 LIMITATIONS 55
1.8 SUMMARY OF CHANGES 56
1.9 RECESSION IMPACT 56
2 RESEARCH METHODOLOGY 57
2.1 RESEARCH DATA 57
FIGURE 1 RESEARCH DESIGN 57
2.1.1 SECONDARY DATA 58
2.1.2 PRIMARY DATA 58
FIGURE 2 MICE MODEL MARKET: BREAKDOWN OF PRIMARIES 59
2.2 MARKET ESTIMATION METHODOLOGY 59
FIGURE 3 MICE MODEL MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 59
2.2.1 BOTTOM-UP APPROACH 60
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 60
FIGURE 5 ILLUSTRATIVE EXAMPLE OF CHARLES RIVER LABORATORIES: REVENUE SHARE ANALYSIS (2023) 61
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 62
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 62
2.3 TOP-DOWN APPROACH 62
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 62
2.4 GROWTH FORECAST 64
FIGURE 8 MICE MODEL MARKET: CAGR PROJECTIONS 64
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 65
FIGURE 9 DATA TRIANGULATION METHODOLOGY 65
2.6 RESEARCH ASSUMPTIONS 66
2.7 MARKET FORECAST 66
TABLE 1 FACTOR ANALYSIS 66
2.8 RISK ANALYSIS 67
2.9 RECESSION IMPACT ANALYSIS 67
3 EXECUTIVE SUMMARY 68
FIGURE 10 MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2024 VS. 2029 (USD MILLION) 68
FIGURE 11 MICE MODEL MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION) 69
FIGURE 12 MICE MODEL MARKET, BY THERAPEUTIC AREA, 2024 VS. 2029 (USD MILLION) 69
FIGURE 13 MICE MODEL MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 70
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MICE MODEL MARKET 71
4 PREMIUM INSIGHTS 72
4.1 MICE MODEL MARKET OVERVIEW 72
FIGURE 15 RISING INVESTMENTS AND ADVANCEMENTS IN MOUSE MODEL TECHNOLOGY TO DRIVE MARKET GROWTH 72
4.2 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE (2023) 73
FIGURE 16 MODEL TYPE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 73
4.3 MICE MODEL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 74
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 74
4.4 MICE MODEL MARKET SHARE, BY END USER 74
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 74
5 MARKET OVERVIEW 75
5.1 INTRODUCTION 75
5.2 MARKET DYNAMICS 75
FIGURE 19 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 75
TABLE 2 MICE MODEL MARKET: IMPACT ANALYSIS 76
5.2.1 DRIVERS 76
5.2.1.1 High adoption of mice models in preclinical studies 76
5.2.1.2 Increasing demand for mouse clinical trials (MCTs) 77
5.2.1.3 Growing preference for personalized medicine in oncology 78
5.2.1.4 Advancements in genetic engineering 78
5.2.2 RESTRAINTS 79
5.2.2.1 Introduction of 3D printed models 79
5.2.2.2 Ethical concerns and regulatory restrictions 79
5.2.3 OPPORTUNITIES 80
5.2.3.1 Utilization of CRISPR in biomedical research 80
5.2.3.2 Rising demand for disease-specific models 80
5.2.4 CHALLENGES 80
5.2.4.1 Development of alternative animal testing methods 80
5.2.4.2 Genetic & Phenotypic variability 81
5.3 MICE MODEL MARKET LANDSCAPE 81
5.3.1 HISTORY OF MICE MODELS 81
5.3.2 MICE MODEL GENERATION PROCESS 81
5.3.3 TECHNIQUES FOR MICE MODEL DEVELOPMENT 82
5.3.4 TECHNOLOGICAL ADVANCEMENTS 83
5.3.5 CONSIDERATIONS FOR MICE MODEL DEVELOPMENT 84
5.4 SUPPLY CHAIN ANALYSIS 84
FIGURE 20 MICE MODEL MARKET: SUPPLY CHAIN ANALYSIS 85
5.5 VALUE CHAIN ANALYSIS 85
FIGURE 21 MICE MODEL MARKET: VALUE CHAIN ANALYSIS 86
5.6 PRICING ANALYSIS 87
TABLE 3 AVERAGE SELLING PRICE TREND OF MODEL TYPE, BY KEY PLAYER 87
5.6.1 AVERAGE SELLING PRICE TREND ANALYSIS 87
5.7 ECOSYSTEM ANALYSIS 88
FIGURE 22 MICE MODEL MARKET: ECOSYSTEM ANALYSIS 88
5.7.1 MICE MODEL VENDORS 89
TABLE 4 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY MICE MODEL VENDORS 89
5.7.2 MICE MODEL SERVICE VENDORS 89
TABLE 5 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY SERVICE VENDOR 90
5.7.3 MICE MODEL END USERS 90
TABLE 6 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY END USER 90
5.7.4 REGULATORY ORGANIZATIONS 91
TABLE 7 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY REGULATORY ORGANIZATION 91
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 91
FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 92
5.9 PATENT ANALYSIS 92
5.9.1 METHODOLOGY 92
5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014−2024 93
TABLE 8 PATENTS FILED (2014−2024) 93
5.9.3 INNOVATION & PATENT APPLICATIONS 93
FIGURE 24 TOTAL NUMBER OF PATENTS GRANTED (2014−2024) 93
5.9.4 TOP APPLICANTS 94
FIGURE 25 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS (2014−2024) 94
TABLE 9 TOP 20 PATENT OWNERS IN MICE MODEL MARKET (2014−2024) 94
TABLE 10 PATENTS IN MICE MODEL MARKET (2024) 95
5.10 KEY CONFERENCES & EVENTS 96
5.10.1 MICE MODEL MARKET: KEY CONFERENCES & EVENTS (2024−2025) 96
TABLE 11 MICE MODEL MARKET: CONFERENCES & EVENTS (2024−2025) 96
5.11 REGULATORY LANDSCAPE 97
5.11.1 REGULATORY ANALYSIS 97
5.11.1.1 North America 97
5.11.1.2 Europe 98
5.11.1.3 China 99
5.11.1.4 Japan 100
5.11.1.5 India 100
5.11.1.6 Australia 101
5.11.1.7 Brazil 101
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 16 MICE MODEL MARKET: REGULATORY SCENARIO 104
5.12 PORTER’S FIVE FORCES ANALYSIS 106
TABLE 17 MICE MODEL MARKET: PORTER’S FIVE FORCES ANALYSIS 106
5.12.1 THREAT OF NEW ENTRANTS 106
5.12.2 THREAT OF SUBSTITUTES 107
5.12.3 BARGAINING POWER OF BUYERS 107
5.12.4 BARGAINING POWER OF SUPPLIERS 107
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 107
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 108
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 108
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICE MODEL MARKET 108
TABLE 18 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICE MODELS & SERVICES 108
5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS 109
5.13.3 BUYING CRITERIA FOR MICE MODEL MARKET 109
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 109
TABLE 19 BUYING CRITERIA FOR MICE MODEL TYPE & SERVICE, BY END USER 110
6 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE 111
6.1 INTRODUCTION 112
TABLE 20 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2022–2029 (USD MILLION) 112
6.2 MODEL TYPES 112
TABLE 21 MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 112
TABLE 22 NORTH AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 23 EUROPE: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 24 ASIA PACIFIC: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 25 LATIN AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 26 MIDDLE EAST: MICE MODEL TYPE MARKET, BY REGION, 2022–2029 (USD MILLION) 114
TABLE 27 GCC COUNTRIES: MICE MODEL TYPE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 28 MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 115
6.2.1 INBRED MICE 115
6.2.1.1 High utilization across research applications to propel market 115
TABLE 29 INBRED MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 116
TABLE 30 NORTH AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 31 EUROPE: INBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 32 ASIA PACIFIC: INBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 33 LATIN AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 34 MIDDLE EAST: INBRED MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 117
TABLE 35 GCC COUNTRIES: INBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 118
6.2.2 GENETICALLY ENGINEERED MICE 118
6.2.2.1 Ability to induce mutations for CVD & cancer research to drive market 118
TABLE 36 GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 119
TABLE 37 NORTH AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 38 EUROPE: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 39 ASIA PACIFIC: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 40 LATIN AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 41 MIDDLE EAST: GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 120
TABLE 42 GCC COUNTRIES: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 121
6.2.3 HYBRID/CONGENIC MICE 121
6.2.3.1 Growing focus on biomedical research to boost demand 121
TABLE 43 HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 122
TABLE 44 NORTH AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 45 EUROPE: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 46 ASIA PACIFIC: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 47 LATIN AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 48 MIDDLE EAST: HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 123
TABLE 49 GCC COUNTRIES: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124
6.2.4 OUTBRED MICE 124
6.2.4.1 Genetic diversity benefits to support market growth 124
TABLE 50 OUTBRED MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 124
TABLE 51 NORTH AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 52 EUROPE: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 53 ASIA PACIFIC: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 54 LATIN AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 55 MIDDLE EAST: OUTBRED MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 126
TABLE 56 GCC COUNTRIES: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
6.3 SERVICES 127
TABLE 57 MICE MODEL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 127
TABLE 58 NORTH AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 59 EUROPE: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 60 ASIA PACIFIC: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 61 LATIN AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 62 MIDDLE EAST: MICE MODEL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 129
TABLE 63 GCC COUNTRIES: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 64 MICE MODEL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 129
6.3.1 BREEDING SERVICES 130
6.3.1.1 Customization of models for specific research applications to boost demand 130
TABLE 65 MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 130
TABLE 66 NORTH AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 67 EUROPE: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 68 ASIA PACIFIC: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 69 LATIN AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 70 MIDDLE EAST: MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 132
TABLE 71 GCC COUNTRIES: MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 132
6.3.2 CRYOPRESERVATION SERVICES 133
6.3.2.1 Rising focus on preservation of novel mice models to propel market 133
TABLE 72 MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 133
TABLE 73 NORTH AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 74 EUROPE: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 75 ASIA PACIFIC: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 76 LATIN AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 77 MIDDLE EAST: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION 2022–2029 (USD MILLION) 135
TABLE 78 GCC COUNTRIES: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136
6.3.3 REDERIVATION SERVICES 136
6.3.3.1 Stringent quality assurance standards to fuel market 136
TABLE 79 MICE MODEL REDERIVATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 136
TABLE 80 NORTH AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 81 EUROPE: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 82 ASIA PACIFIC: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 83 LATIN AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 84 MIDDLE EAST: MICE MODEL REDERIVATION SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 138
TABLE 85 GCC COUNTRIES: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139
6.3.4 QUARANTINE SERVICES 139
6.3.4.1 Rising demand for germ-free mice to support market growth 139
TABLE 86 MICE MODEL QUARANTINE SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 140
TABLE 87 NORTH AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 88 EUROPE: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 89 ASIA PACIFIC: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 90 LATIN AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 91 MIDDLE EAST: MICE MODEL QUARANTINE SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 142
TABLE 92 GCC COUNTRIES: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
6.3.5 OTHER SERVICES 143
TABLE 93 MICE MODEL OTHER SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 143
TABLE 94 NORTH AMERICA: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 95 EUROPE: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 96 ASIA PACIFIC: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 97 LATIN AMERICA: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 98 MIDDLE EAST: MICE MODEL OTHER SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 145
TABLE 99 GCC COUNTRIES: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146
7 MICE MODEL MARKET, BY TECHNOLOGY 147
7.1 INTRODUCTION 148
TABLE 100 MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 148
7.2 CRISPR/CAS9 148
7.2.1 ADVANTAGES SUCH AS SIMPLIFIED DESIGN AND COST EFFICIENCY TO BOOST DEMAND 148
TABLE 101 CRISPR/CAS9 MARKET, BY REGION, 2022–2029 (USD MILLION) 149
TABLE 102 NORTH AMERICA: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 103 EUROPE: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 104 ASIA PACIFIC: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 105 LATIN AMERICA: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 106 MIDDLE EAST: CRISPR/CAS9 MARKET, BY REGION, 2022–2029 (USD MILLION) 150
TABLE 107 GCC COUNTRIES: CRISPR/CAS9 MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 151
7.3 MICROINJECTION 151
7.3.1 LOW TOXICITY AND HIGH SUCCESS RATE TO PROPEL MARKET 151
TABLE 108 MICROINJECTION MARKET, BY REGION, 2022–2029 (USD MILLION) 152
TABLE 109 NORTH AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 110 EUROPE: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 111 ASIA PACIFIC: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 112 LATIN AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 113 MIDDLE EAST: MICROINJECTION MARKET, BY REGION, 2022–2029 (USD MILLION) 153
TABLE 114 GCC COUNTRIES: MICROINJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154
7.4 EMBRYONIC STEM CELL INJECTION 154
7.4.1 RISING DEMAND FOR TARGETED MICE MODELS IN IMMUNOLOGICAL RESEARCH TO DRIVE MARKET 154
TABLE 115 EMBRYONIC STEM CELL INJECTION MARKET, BY REGION, 2022–2029 (USD MILLION) 155
TABLE 116 NORTH AMERICA: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 117 EUROPE: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 118 ASIA PACIFIC: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 119 LATIN AMERICA: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 120 MIDDLE EAST: EMBRYONIC STEM CELL INJECTION MARKET, BY REGION, 2022–2029 (USD MILLION) 156
TABLE 121 GCC COUNTRIES: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157
7.5 NUCLEAR TRANSFER 157
7.5.1 POTENTIAL TO PRODUCE IDENTICAL MICE TO DRIVE MARKET 157
TABLE 122 NUCLEAR TRANSFER MARKET, BY REGION, 2022–2029 (USD MILLION) 158
TABLE 123 NORTH AMERICA: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 124 EUROPE: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 125 ASIA PACIFIC: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 126 LATIN AMERICA: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 159
TABLE 127 MIDDLE EAST: NUCLEAR TRANSFER MARKET, BY REGION, 2022–2029 (USD MILLION) 159
TABLE 128 GCC COUNTRIES: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 160
7.6 OTHER TECHNOLOGIES 160
TABLE 129 OTHER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION) 161
TABLE 130 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 131 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 132 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 133 LATIN AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 134 MIDDLE EAST: OTHER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION) 162
TABLE 135 GCC COUNTRIES: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 163
8 MICE MODEL MARKET, BY THERAPEUTIC AREA 164
8.1 INTRODUCTION 165
TABLE 136 MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 165
8.2 ONCOLOGY 165
8.2.1 GROWING FOCUS ON ONCOLOGY THERAPEUTIC DEVELOPMENT TO PROPEL MARKET 165
TABLE 137 MICE MODEL MARKET FOR ONCOLOGY, BY REGION, 2022–2029 (USD MILLION) 166
TABLE 138 NORTH AMERICA: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 139 EUROPE: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 140 ASIA PACIFIC: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 141 LATIN AMERICA: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 142 MIDDLE EAST: MICE MODEL MARKET FOR ONCOLOGY, BY REGION, 2022–2029 (USD MILLION) 168
TABLE 143 GCC COUNTRIES: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 168
8.3 METABOLIC DISEASES 169
8.3.1 RISING PREVALENCE OF DIABETES TO DRIVE MARKET 169
TABLE 144 MICE MODEL MARKET FOR METABOLIC DISEASES, BY REGION, 2022–2029 (USD MILLION) 169
TABLE 145 NORTH AMERICA: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 146 EUROPE: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 147 ASIA PACIFIC: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 148 LATIN AMERICA: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 149 MIDDLE EAST: MICE MODEL MARKET FOR METABOLIC DISEASES, BY REGION, 2022–2029 (USD MILLION) 171
TABLE 150 GCC COUNTRIES: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 172
8.4 IMMUNOLOGY 172
8.4.1 INCREASING CLINICAL RESEARCH FOR IMMUNOLOGICAL DISORDERS TO FUEL MARKET 172
TABLE 151 MICE MODEL MARKET FOR IMMUNOLOGY, BY REGION, 2022–2029 (USD MILLION) 173
TABLE 152 NORTH AMERICA: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 153 EUROPE: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 154 ASIA PACIFIC: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 155 LATIN AMERICA: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 156 MIDDLE EAST: MICE MODEL MARKET FOR IMMUNOLOGY, BY REGION, 2022–2029 (USD MILLION) 174
TABLE 157 GCC COUNTRIES: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 175
8.5 NEUROLOGY 175
8.5.1 INCREASING INVESTMENTS IN R&D FOR CNS DISEASES TO SUPPORT MARKET GROWTH 175
TABLE 158 MICE MODEL MARKET FOR NEUROLOGY, BY REGION, 2022–2029 (USD MILLION) 176
TABLE 159 NORTH AMERICA: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 160 EUROPE: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 161 ASIA PACIFIC: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 162 LATIN AMERICA: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 163 MIDDLE EAST: MICE MODEL MARKET FOR NEUROLOGY, BY REGION, 2022–2029 (USD MILLION) 177
TABLE 164 GCC COUNTRIES: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 178
8.6 CARDIOVASCULAR DISEASES 178
8.6.1 GROWING FOCUS ON TARGETED TREATMENTS FOR CVD TO BOOST DEMAND 178
TABLE 165 MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022–2029 (USD MILLION) 179
TABLE 166 NORTH AMERICA: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 167 EUROPE: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 168 ASIA PACIFIC: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 169 LATIN AMERICA: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 170 MIDDLE EAST: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022–2029 (USD MILLION) 180
TABLE 171 GCC COUNTRIES: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 181
8.7 OTHER THERAPEUTIC AREAS 181
TABLE 172 MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2022–2029 (USD MILLION) 182
TABLE 173 NORTH AMERICA: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 174 EUROPE: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 175 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 176 LATIN AMERICA: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 177 MIDDLE EAST: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2022–2029 (USD MILLION) 183
TABLE 178 GCC COUNTRIES: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022–2029 (USD MILLION) 184
9 MICE MODEL MARKET, BY APPLICATION 185
9.1 INTRODUCTION 186
TABLE 179 MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 186
9.2 DRUG DISCOVERY & DEVELOPMENT 186
9.2.1 RISING NUMBER OF CLINICAL TRIALS TO DRIVE MARKET 186
TABLE 180 MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 187
TABLE 181 NORTH AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 182 EUROPE: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 183 ASIA PACIFIC: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 184 LATIN AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 185 MIDDLE EAST: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 186 GCC COUNTRIES: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 189
9.3 RESEARCH APPLICATIONS 189
9.3.1 RISING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND 189
TABLE 187 MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 190
TABLE 188 NORTH AMERICA: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 189 EUROPE: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 190 ASIA PACIFIC: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 191 LATIN AMERICA: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 192 MIDDLE EAST: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 193 GCC COUNTRIES: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 192
9.4 PERSONALIZED MEDICINE 192
9.4.1 GROWING PREFERENCE FOR ONCOLOGY THERAPEUTICS TO PROPEL MARKET 192
TABLE 194 MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2022–2029 (USD MILLION) 193
TABLE 195 NORTH AMERICA: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 196 EUROPE: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 197 ASIA PACIFIC: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 198 LATIN AMERICA: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 199 MIDDLE EAST: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 200 GCC COUNTRIES: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION) 195
10 MICE MODEL MARKET, BY END USER 196
10.1 INTRODUCTION 197
TABLE 201 MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION) 197
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 197
10.2.1 RISING EXPENDITURE ON R&D FOR DRUG DEVELOPMENT TO BOOST DEMAND 197
TABLE 202 MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 198
TABLE 203 NORTH AMERICA: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 204 EUROPE: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 205 ASIA PACIFIC: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 206 LATIN AMERICA: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 200
TABLE 207 MIDDLE EAST: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 200
TABLE 208 GCC COUNTRIES: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 200
10.3 ACADEMIC & RESEARCH INSTITUTES 201
10.3.1 INCREASING FUNDING INITIATIVES FOR LIFE SCIENCES R&D TO SUPPORT MARKET GROWTH 201
TABLE 209 MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 201
TABLE 210 NORTH AMERICA: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 211 EUROPE: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 212 ASIA PACIFIC: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 213 LATIN AMERICA: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 203
TABLE 214 MIDDLE EAST: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 203
TABLE 215 GCC COUNTRIES: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 203
10.4 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS 204
10.4.1 RISING OUTSOURCING OF DRUG DISCOVERY SERVICES TO PROPEL MARKET 204
TABLE 216 MICE MODEL MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION) 204
TABLE 217 NORTH AMERICA: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 218 EUROPE: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 219 ASIA PACIFIC: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 220 LATIN AMERICA: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 USD MILLION) 206
TABLE 221 MIDDLE EAST: MICE MODEL MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION) 206
TABLE 222 GCC COUNTRIES: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 206
11 MICE MODEL MARKET, BY REGION 207
11.1 INTRODUCTION 208
TABLE 223 MICE MODEL MARKET, BY REGION, 2022–2029 (USD MILLION) 208
11.2 NORTH AMERICA 208
11.2.1 NORTH AMERICA: RECESSION IMPACT 208
FIGURE 28 NORTH AMERICA: MICE MODEL MARKET SNAPSHOT 209
TABLE 224 NORTH AMERICA: MICE MODEL MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 225 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 210
TABLE 226 NORTH AMERICA: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 227 NORTH AMERICA: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 211
TABLE 228 NORTH AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 211
TABLE 229 NORTH AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 212
TABLE 230 NORTH AMERICA: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 212
TABLE 231 NORTH AMERICA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 212
11.2.2 US 213
11.2.2.1 Rising production of monoclonal antibodies to fuel market for mice models 213
TABLE 232 US: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 214
TABLE 233 US: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 234 US: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 214
TABLE 235 US: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 215
TABLE 236 US: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 215
TABLE 237 US: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 215
TABLE 238 US: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 216
11.2.3 CANADA 216
11.2.3.1 Growth in stem cell research activities to support market growth 216
TABLE 239 CANADA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022–2029 (USD MILLION) 216
TABLE 240 CANADA: MICE MODEL MARKET, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 241 CANADA: MICE MODEL MARKET, BY SERVICE, 2022–2029 (USD MILLION) 217
TABLE 242 CANADA: MICE MODEL MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 217
TABLE 243 CANADA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022–2029 (USD MILLION) 218
TABLE 244 CANADA: MICE MODEL MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 218
TABLE 245 CANADA: MICE MODEL MARKET, BY END USER, 2022–2029 (USD MILLION 218

※본 조사보고서 [세계의 마우스 모델 시장 (~2029년) : 근교계, 이계 교배, 하이브리드] (코드 : BT2192-24) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 마우스 모델 시장 (~2029년) : 근교계, 이계 교배, 하이브리드] 에 대해서 E메일 문의는 여기를 클릭하세요.

*** 아래는 관련 보고서 소개입니다 ***

세계의 체외 독성 검사 시장 (~2028년) : 제품 및 서비스별 (분석법 (ELISA, 웨스턴블롯), 기기, 소모품, 소프트웨어), 독성 종점별 (ADME, 유전 독성, 세포 독성), 기술별, 방법론별, 산업별 (제약, 화장품)
BT2373-23 / MarketsandMarkets / 2023년 10월 / "세계의 체외 독성 검사 시장은 예측 기간 중 연평균 성장률 9.5%을 기록하여, 2023년 108억 달러에서 2028년 171억 달러에 이를 것으로 전망됩니다."이 시장의 성장은 독물학 기기의 기술적 진보, 조기 독성 검출을...1. 소개 2. 조사 방법 3. 개요 4. 프리미엄 인사이트 5. 시장 개요 6. 세계의 체외 독성 검사 시장 분석 : 제품 및 서비스별 7. 세계의 체외 독성 검사 시장 분석 : 독성 엔드포인트별 8. 세계의 체외 독성 검사 시장 분석 : 산업별 9. 세계의 체외 독성 검사 시장 분석...

세계의 수복 치과 시장 (~2028년) : 제품별 (재료별 (복합재, 글래스 아이오노머, 접착제, 금속), 회전 기기별, 장비별 (CAD/CAM, 구강내 스캐너, CBCT, X선)), 최종 용도별 (DSO, 클리닉, 병원), 충치 종류별
MD5593-23 / MarketsandMarkets / 2023년 11월 / "글로벌 수복 치과 시장은 2023년 56억 달러에서 2028년까지 연평균 5.5%의 성장률로 74억 달러에 달할 것으로 전망됩니다."고급 미용 치과 시술의 보급률 증가, 가처분 소득의 증가에 따라 다양한 국가에서 고가의 미용 시술을...1. 소개 2. 조사 방법 3. 개요 4. 프리미엄 인사이트 5. 시장 개요 6. 세계의 수복 치과 시장 규모 : 충치 유형별 7. 세계의 수복 치과 시장 규모 : 제품별 8. 세계의 수복 치과 시장 규모 : 최종 용도별 9. 세계의 수복 치과 시장 규모 : 지역별 10. 경쟁 현황...

세계의 엑소좀 연구 시장 (~2028년) : 키트, 시약 (항체, 분리 정제), 기기
BT6939-24 / MarketsandMarkets / 2024년 1월 / "글로벌 엑소좀 연구 시장은 2023년 약 1억 6900만 달러에서 2028년 35억 6000만 달러에 달할 것으로 예상되며, 예측 기간 동안 16.0%의 CAGR을 기록할 것으로 전망됩니다." 이 시장의 성장은 암, 신경 퇴행성...1. 서론 2. 조사 방법 3. 개요 4. 프리미엄 인사이트 5. 시장 개요 6. 세계의 엑소좀 연구 시장 규모 : 제품 및 서비스별 7. 세계의 엑소좀 연구 시장 규모 : 질환별 8. 세계의 엑소좀 연구 시장 규모 : 용도별 9. 세계의 엑소좀 연구 시장 규모 : 최종 용도별 10. 세계의...

세계의 신약개발 인공지능 (AI) 시장 (~2029년) : 프로세스별 (타겟, 리드), 유스케이스별 (디자인 및 최적화, 백신, 항체, 질병 이해, PK/PD), 치료별 (암, 중추신경계, CVS), 툴별 (ML :DL (CNN, GAN)), 최종 사용자별, 지역별
HIT 7445 / MarketsandMarkets / 2024년 11월 / ...“세계 신약개발 인공지능 (AI) 시장은 2024년 18.6억 달러에서 2029년에는 68.9억 달러에 달할 것으로 예상되며, 2024년부터 2029년까지 연평균 성장률은 29.9%로 전망” 산업을 초월한 협업과 파트너십의 증가는 신약 개발 공급망의 다양한 측면에서 전문 지식, 자원, 기술을 결합하여 신약개발 인공지능 (AI) 시장의 성장을 촉진할 것입니다. 예를 들어, 2024년 3월, 코그니잔트는 BioNeMo 플랫폼을 통해...

세계의 구조 심장 장치 시장 (~2029년) : 제품별 (경카테터, 외과용 심장밸브장치, 오클루더, 폐쇄 및 전달 시스템, 환형 형성 링, 부속품), 시술별 (대체 (TAVR/TAVI), 수리), 최종 사용자별
MD 6585 / MarketsandMarkets / 2024년 12월 / ...“세계의 구조 심장 장치 시장은 2024년 163.1억 달러에서 2029년에는 256.9억 달러에 이를 것으로 전망되며, 2024년부터 2029년까지 연평균 성장률은 9.5%”심장판막증과 선천성 심장병의 발병률 상승, TAVR과 TMVR 등 최소침습기술의 높은 발전률, 세계적인 인구 고령화와 의료 인프라 강화에 따른 채용률 상승 등이 심장구조기기 시장의 성장 촉진 요인입니다. “제품 부문별로 보면 예측 기간 동안...

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!